Patents Examined by Jianfeng Song
  • Patent number: 11351182
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: June 7, 2022
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
  • Patent number: 11337972
    Abstract: A pharmaceutical preparation includes a first active component, a second active component and pharmaceutically acceptable excipients. The first active component is at least one selected from the group consisting of a neutral endopeptidase inhibitor and a precursor, an active metabolite, a stereoisomer, a pharmaceutically acceptable salt, a prodrug and a solvate thereof. The second active component is at least one selected from the group consisting of a compound represented by the following formula (I) or a precursor, an active metabolite, a stereoisomer, a pharmaceutically acceptable salt, a prodrug and a solvate thereof. The pharmaceutically acceptable excipients include one or more disintegrants and/or one or more fillers.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: May 24, 2022
    Assignees: WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD., WUHAN QR PHARMACEUTICALS CO., LTD., WUHAN ZY PHARMACEUTICALS CO., LTD.
    Inventors: Xiaojing Hu, Lina Qian, Zhichao Zhang, Yuanping Wang, Yongkai Chen, Wei Feng, Wenwen Qi, Chaodong Wang
  • Patent number: 11331389
    Abstract: The present invention relates to the field of carrier and delivery systems for active molecular compounds. In particular, the present invention provides aqueous dispersions for delivery of active molecular compounds.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: May 17, 2022
    Assignee: Austin Research Labs Corp.
    Inventors: Jai Supamahitorn, Lauren McMillan
  • Patent number: 11331410
    Abstract: Compositions and blends of biopolymers and copolymers are described, along with their use to prepare biocompatible scaffolds and surgically implantable devices for use in supporting and facilitating the repair of soft tissue injuries.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: May 17, 2022
    Assignee: EMBODY, INC.
    Inventors: Michael Francis, Nathan Kemper, Hilary Wriggers
  • Patent number: 11331412
    Abstract: In one embodiment, the present invention provides a composition, wherein the composition is a porous scaffold, wherein the pores of the scaffold are from 1 to 500 microns, the composition comprising: a) a cross-linkable protein selected from the group consisting of collagen and gelatin; b) a cross-linker which induces cross-linking of the cross-linkable protein; and c) a liquid.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: May 17, 2022
    Assignee: BIO-CHANGE LTD.
    Inventors: Ishay Attar, Shay Yaacov Sherbo Zheli
  • Patent number: 11331340
    Abstract: Compositions are described comprising a polymer; a non-physiological pH solution; and a visualization agent; wherein the polymer is soluble in the non-physiological pH solution and insoluble at a physiological pH. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: May 17, 2022
    Assignee: MicroVention, Inc.
    Inventors: Gregory M. Cruise, Michael J. Constant, Joshua Garretson
  • Patent number: 11332483
    Abstract: The present disclosure relates gold carbene naphthoquinone compounds and salts thereof. In some aspects, these compounds can be used to treat cancer including cancers which are resistant to one or more other chemotherapeutic agents such as cisplatin or platinum chemotherapeutic agents. Also provided herein are pharmaceutical compositions comprising the gold carbene naphthoquinone compounds.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: May 17, 2022
    Assignees: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, GEORGIA SOUTHERN UNIVERSITY, WRIGHT STATE UNIVERSITY
    Inventors: Jonathan Arambula, Kuppuswamy Arumugam, Jonathan L. Sessler, Christopher Bielawski
  • Patent number: 11324670
    Abstract: The present invention is a cocoa butter powdered moisturizer with the addition of cocoa powder serving as a stabilizing agent. The cocoa butter is grated and/or shredded into a fine granulated form and is supplemented with the stabilizing cocoa powder such that the resulting moisturizer attains a consistent, usable form. The resulting moisturizer is stable at room temperature and provides an SPF-15 level of sun protection for the skin.
    Type: Grant
    Filed: October 16, 2014
    Date of Patent: May 10, 2022
    Inventors: Bilal Walk, Elizabeth Handy
  • Patent number: 11318084
    Abstract: Provided is an elastomer that improves the skin feel of an inorganic powder. The elastomer according to the present invention is an elastomer comprising: (A) an amino group-containing silicone polymer; and (B) a carboxyl group-containing silicone polymer or a carboxyl group-containing acrylamide polymer, wherein a molar ratio Y/X between amino groups and carboxyl groups is within a range of 0.1 to 1.2, wherein Y denotes the molar amount of carboxyl groups contained in the component (B), and X denotes the molar amount of amino groups contained in the component (A).
    Type: Grant
    Filed: May 29, 2017
    Date of Patent: May 3, 2022
    Assignee: SHISEIDO COMPANY, LTD.
    Inventors: Tomo Osawa, Ayano Matsuo, Yuji Sonoyama, Tomoko Ikeda, Shun Kubota, Mao Hitomi, Takuya Hiruma, Tetsuya Kanemaru
  • Patent number: 11311651
    Abstract: Provided are an absorbable biomedical composite material and a preparation method therefor. The absorbable biomedical composite material comprises: substrate granules containing a calcium-phosphorus compound; an intermediate layer which is coated on the surface of each of the substrate granules and has a first glass transition temperature, the first glass transition temperature being not higher than normal human body temperature; and a polymer matrix which is formed on the outer surface of the intermediate layer and has a second glass transition temperature, the second glass transition being higher than the first glass transition temperature. The absorbable biomedical composite material has increased mechanical strength and also improved toughness.
    Type: Grant
    Filed: July 15, 2018
    Date of Patent: April 26, 2022
    Assignee: SHENZHEN CORLIBER SCIENTIFIC CO., LTD.
    Inventors: Yang Sun, Feng Pan, Yucheng Huang, Dong Xiang
  • Patent number: 11304959
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: April 19, 2022
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
  • Patent number: 11304886
    Abstract: N-Acyl sarcosines of Formula I, wherein, R?C7 alkyl and C10 alkenyl group with terminal double bond, are described as new antimicrobial preservatives for home and personal care products. Lipidated sarcosines of this patent application preserve creams, lotions, emulsions, solutions or suspensions types of formulations of personal care industry. These are used in: leave-on?? (cold cream, sunscreen) as well as: rinse-off?? (facewash, body wash, shampoo) formulations either alone or in combination with other antimicrobials.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: April 19, 2022
    Assignee: GALAXY SURFACTANTS LTD.
    Inventors: Bhagyesh Jagannath Sawant, Devyani Ashok Mali, Arpit Wankhade, Nirmal Koshti
  • Patent number: 11304912
    Abstract: The present application relates to a transdermal therapeutic system comprising a backing layer impermeable to active substances and a polymer matrix on one side of the backing layer impermeable to active substances, wherein the polymer matrix comprises at least one pharmaceutically active substance, at least one inherently non-self-adhesive polymer and at least one plasticizer, said polymer matrix being free of adhesive polymers. The invention further relates to a method of producing the transdermal therapeutic system and to the use thereof as a drug.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: April 19, 2022
    Assignee: LTS LOHMANN THERAPIE-SYSTEME AG
    Inventors: Michael Linn, Markus Müller, Marius Bauer
  • Patent number: 11298374
    Abstract: The present disclosure relates to methods and devices to improve respiratory system health, increase resistance to infection, and increase the hypothiocyanate ion in mammalian lungs. The methods generally comprise: generating a Hydrogen Peroxide Gas that is non-hydrated and free of ozone, and directing the gas comprising primarily Hydrogen Peroxide Gas into an environment and exposing a subject to the environment such that the Hydrogen Peroxide Gas acts to the increase of the hypothiocyanate ion in mammalian lungs.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: April 12, 2022
    Inventor: James D. Lee
  • Patent number: 11291630
    Abstract: The present invention relates to gelling compositions, which changes from liquid state to gel state in function of temperature comprising: at least a poloxamer or mixture of poloxamers; at least a gelling agent; and at least an anticancer agent. Said compositions are advantageously used for local administration of an anticancer agent. Said compositions are useful for size-reduction of a tumour before surgical removal of said tumour, for preventing tumour recurrence after surgical removal of a tumour, and/or treating small tumours. They are therefore useful for the treatment of cancer, preferably a cancer of a wall of the digestive system or a gynaecologic cancer. The present invention also relates to a method for preparing said gelling compositions.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: April 5, 2022
    Inventors: Nathalie Mignet, Vincent Pierre-Marie Boudy, Johanne Seguin, Daniel Scherman, Yoran Beldengrun
  • Patent number: 11273106
    Abstract: Cosmetic compositions or agents and methods for the temporary shaping of keratinous fibers are provided. In an embodiment, a cosmetic composition contains from about 2.0 to about 8.0 wt. % hydrophobized metal oxide powder; from about 0.01 to about 2.0 wt. % carbon-based adsorption agent; from about 3.0 to about 35 wt. % lipid; from about 1.0 to about 10 wt. % emulsifier; and from about 30 to about 50 wt. % water. Embodiments include the use of such cosmetic compositions and methods for employing such compositions.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: March 15, 2022
    Assignee: HENKEL AG & CO. KGAA
    Inventors: Nora Koopmann, Anna Puls
  • Patent number: 11241445
    Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: February 8, 2022
    Assignee: TherapeuticsMD, Inc.
    Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
  • Patent number: 11234929
    Abstract: The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: February 1, 2022
    Assignee: Alcon Inc.
    Inventors: Howard Allen Ketelson, David L. Meadows
  • Patent number: 11229604
    Abstract: Microspheres, compositions including the microspheres, and methods of using the microspheres are disclosed herein. The microspheres can be substantially spherical and can include a copolymer of a monomer (such as an acrylic monomer) and a cyclodextrin or a derivative thereof. The microspheres can also include a therapeutic agent, such as a platinum-based drug.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: January 25, 2022
    Assignee: Biosphere Medical, Inc.
    Inventors: Philippe Reb, Meriadeg Thomas
  • Patent number: 11202740
    Abstract: Described herein is dosage of foam including from about 5 cm3 to about 70 cm3 of the foam. The foam includes from about 0.5 g to about 4 g of a detersive surfactant; from about 0.001 g to about 4 g propellant; a foam density of from about 0.02 g/cm3 to about 0.25 g/cm3; and a bubble size distribution having an R32 of from about 5 ?m to about 150 ?m.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: December 21, 2021
    Assignee: The Procter and Gamble Company
    Inventors: Jazmin Veronica Torres Rivera, Eric Scott Johnson, Sarah Elizabeth Mullen, Sean Michael Renock, Todd Ryan Thompson, Jean Jianqun Zhao, Robert Wayne Glenn, Jr.